EGFR and triple-negative breast carcinoma: The aptamer has excellent capability to recognize EGFR-positive cells belonging to different cancer types [19, 20], including human epidermal growth factor receptor 2 (HER2)-positive tumors [21, 22] and triple-negative breast cancer (TNBC) [23].